Nusantara Science and Technology Proceedings · Jul 9, 2026
Unravelling the Essential Role of Podocyte Senescence in Chronic Kidney Disease
By Sulistyoningrum E, Arfian N, Susilowati R
Podocyte senescence has emerged as a fundamental mechanism underlying chronic kidney aging. Podocytes, terminally differentiated cells essential for preserving the glomerular function, are vulnerable to stress-induced injury. This narrative review summarizes current knowledge of podocyte senescence, its molecular changes during senescence, and therapeutic opportunities. Relevant literature was identified through a targeted search of PubMed, Scopus, SpringerNatureLink, and ScienceDirect using keywords related to podocyte, senescence, aging, senescence-associated secretory phenotype, chronic kidney disease, glomerulosclerosis, p16, and SA-?-Gal up to September 2025. Studies were selected based on their relevance to the conceptual framework of this review. With advanced age, podocytes evidenced hallmarks of senescence, including permanent cell-cycle arrest, DNA damage, and mitochondrial dysfunction. Senescent podocytes exhibit not only structural and functional impairment but also adopt a senescence-associated secretory phenotype that releases pro-inflammatory cytokines, chemokines, growth factors, and proteases. These changes contribute to proteinuria, glomerulosclerosis, and tubulointerstitial fibrosis. Evidence from both preclinical and human kidney biopsies revealed the correlation between podocyte senescence, podocyte depletion, and declining renal function. Emerging therapeutic modalities, such as senolytics, senomorphics, and dietary restrictions, show promising opportunities to mitigate age-related kidney disease. In conclusion, podocyte senescence is a major mechanism in chronic kidney disease progression, representing both a biomarker and therapeutic target. Further studies are needed to refine senescence detection methods, validate interventions, and translate findings into clinical practice.